We did not observe a significant difference in SMAD9 expression between MYCN-nonamplified and MYCN-amplified cell lines and tissues, but MYCN-high NB tissues (classified by the median expression) had a significantly higher SMAD9 level than MYCN-low NB tissues (Fig. S5B). The gene discussed is MYCN; the disease is neuroblastoma.